SEMAGLUTIDE | OZEMPIC | MOUNJARO: MAKING THE CASE FOR GLP-1 AGONIST MEDICATIONS [wellbutrin narcan diet pill]
| 1h 28m 28s | Video has closed captioning.
Today Dayna Summers joins me to talk about the pros and cons of her experience with 3 different GLP-1 agonists (Semaglutide, Ozempic, and Mounjaro) and what led to her choice to begin taking them. After a complicated upbringing, Dayna went on to become a marathon runner, triathlete, and bodybuilder. She built her Real Estate brokerage from the ground up & is now among the top 1% of realtors, nationwide. While at the top of her game in 2017, complications in her personal life lead to an onslaught of stress, weight gain, and a devastating diagnosis of type 2 diabetes. A lot of us have heard the buzz surrounding these weight loss prescriptions, and most of us know at least one person who is taking them. Ozempic, Mounjaro, Wegovy, and Semaglutide are names that, by now, many of us are familiar with. The reaction from the public regarding these medications is pretty split, depending on who you ask. Some will suggest that those who decide to go the route of weight loss prescriptions are taking the easy way out. They are accused of being lazy, lacking discipline & will power. As with most polarizing topics, there are two sides to consider before rushing to judgment and I think Dayna’s story will help us understand things a bit differently. Subscribe to Humanity Unlocked on Apple Podcasts! Follow us on Instagram! Find us on TikTok! #GLP1 #GLP1agonists #weightloss #type2diabetes #health #fitness #wellness #motivation #inspiration #podcast #ozempicweightloss #wegovyweightloss #mounjaroweightloss #semaglutideweightloss #weightlossmedication
Aired: May 28, 2025
Buy Now:
Problems Playing Video? | Closed Captioning